LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
Piper Sandler Reiterates Overweight on LivaNova, Raises Price Target to $90
LivaNova: Careful About The Valuation And Upside
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
LivaNova (LIVN) Q2 2026 Earnings Call Transcript
LivaNova PLC Q2 2026 Earnings Call Summary
LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record Revenue and EPS, Raised Guidance ...
LivaNova Q2 Earnings Call Highlights
LivaNova PLC 2026 Q2 - Results - Earnings Call Presentation
Needham Maintains Buy on LivaNova, Raises Price Target to $93
LivaNova PLC (LIVN) Q2 2026 Earnings Call Transcript
LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say
LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?
LivaNova exceeds second-quarter forecasts and increases 2026 outlook
LivaNova (NASDAQ:LIVN) Beats Q2 Earnings Estimates and Raises Full-Year Guidance
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates
LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.